These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31836832)

  • 41. [Pathogenesis of thyroid eye disease - does autoimmunity against the TSH receptor explain all cases?].
    Wall JR; Lahooti H
    Endokrynol Pol; 2011; 62 Suppl 1():1-7. PubMed ID: 22125104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathogenesis of thyroid eye disease--does autoimmunity against the TSH receptor explain all cases?
    Wall JR; Lahooti H
    Endokrynol Pol; 2010; 61(2):222-7. PubMed ID: 20464711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Variation in the use of definitive treatment options in the management of Graves' disease: a UK clinician survey.
    Hookham J; Collins EE; Allahabadia A; Balasubramanian SP
    Postgrad Med J; 2017 Apr; 93(1098):198-204. PubMed ID: 27531964
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary Care Research Team Assessment (PCRTA): development and evaluation.
    Carter YH; Shaw S; Macfarlane F
    Occas Pap R Coll Gen Pract; 2002 Feb; (81):iii-vi, 1-72. PubMed ID: 12049028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk Factors of Thyroid Eye Disease.
    Lee MH; Chin YH; Ng CH; Nistala KRY; Ow ZGW; Sundar G; Yang SP; Khoo CM
    Endocr Pract; 2021 Mar; 27(3):245-253. PubMed ID: 33655885
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum Vitamin D Deficiency Is an Independent Risk Factor for Thyroid Eye Disease.
    Heisel CJ; Riddering AL; Andrews CA; Kahana A
    Ophthalmic Plast Reconstr Surg; 2020; 36(1):17-20. PubMed ID: 31568022
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early use of steroid-sparing agents in the inactivation of moderate-to-severe active thyroid eye disease: a step-down approach.
    Sipkova Z; Insull EA; David J; Turner HE; Keren S; Norris JH
    Clin Endocrinol (Oxf); 2018 Dec; 89(6):834-839. PubMed ID: 30103255
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cigarette smoking and thyroid eye disease: a systematic review.
    Thornton J; Kelly SP; Harrison RA; Edwards R
    Eye (Lond); 2007 Sep; 21(9):1135-45. PubMed ID: 16980921
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thyroid-associated ophthalmopathy in juvenile Graves' disease--clinical, endocrine and therapeutic aspects.
    Krassas GE; Gogakos A
    J Pediatr Endocrinol Metab; 2006 Oct; 19(10):1193-206. PubMed ID: 17172081
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The eye and thyroid disease.
    Kuriyan AE; Phipps RP; Feldon SE
    Curr Opin Ophthalmol; 2008 Nov; 19(6):499-506. PubMed ID: 18854695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A 2011 survey of clinical practice patterns in the management of Graves' disease.
    Burch HB; Burman KD; Cooper DS
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4549-58. PubMed ID: 23043191
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thyroid Eye Disease: Navigating the New Treatment Landscape.
    Dosiou C; Kossler AL
    J Endocr Soc; 2021 May; 5(5):bvab034. PubMed ID: 33948524
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of Graves' orbitopathy in Latin America: an international questionnaire study compared with Europe.
    Ramos HE; Diehl LA; Camacho CP; Perros P; Graf H;
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):951-6. PubMed ID: 18462263
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Access to intraoperative tumour margin control: a survey of the British Oculoplastic Surgery Society.
    Oliphant H; Oliphant T; Clarke L; Vize C; Rajak S
    Eye (Lond); 2020 Sep; 34(9):1679-1684. PubMed ID: 31896806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. National survey on the management of lacrimal canalicular injury in the United Kingdom.
    Ho T; Lee V
    Clin Exp Ophthalmol; 2006; 34(1):39-43. PubMed ID: 16451257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pediatric Thyroid Eye Disease: Clinical Characteristics and Orbital Decompression Outcomes.
    Chua MR; Tomlinson LA; Binenbaum G; Katowitz WR
    Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S52-S55. PubMed ID: 29985836
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adalimumab as steroid-sparing treatment of inflammatory-stage thyroid eye disease.
    Ayabe R; Rootman DB; Hwang CJ; Ben-Artzi A; Goldberg R
    Ophthalmic Plast Reconstr Surg; 2014; 30(5):415-9. PubMed ID: 24978425
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Severe Pediatric Thyroid Eye Disease: Surgical Case Series.
    Wu CY; Elner VM; Kahana A
    Ophthalmic Plast Reconstr Surg; 2017; 33(3S Suppl 1):S186-S188. PubMed ID: 26524159
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oculoplastic publication trends in general ophthalmology journals.
    Dray JP; Khatib N; Souied E; Saeed P; Simon GB; Gildener-Leapman J; Zloto O
    Int J Ophthalmol; 2022; 15(11):1852-1856. PubMed ID: 36404960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.